Un “perro rastreador” contra el carcinoma de próstata
Entrevista con dr. Wolfgang Wadsak en Onko News Austria, N° 7-8, octubre de 2023 (aleman)
Con la terapia con radioligandos PSMA, la medicina nuclear ofrece un procedimiento prometedor y no invasivo para el diagnóstico y tratamiento del cáncer de próstata, que apenas tiene efectos secundarios y que además tiene un efecto de prolongación de la vida incluso en la fase final al mismo tiempo manteniendo una buena calidad de vida.
Die Zukunft hat begonnen. Therapie auf dem nächsten Level.
The future has started. Experience therapy on the next level.
El futuro ha comenzado. Terapia del siguiente nivel.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Therapie der Zukunft: we fight your cancer
